Studies Show Certain Protein Could Benefit Multiple Sclerosis
Future implications of this research
As the research team researches future applications of IL-35 on neurodegenerative diseases, the hope for a cure for multiple sclerosis moves one step closer. Currently, Dr. Egwuagu and his team are studying the effects of the IL-12p35 subunit on diabetic retinopathy and macular degeneration, diseases that affect the eyes. Other teams turn their attention toward applying the subunit to an effective and available treatment in humans, the first step of which is approval for and then conduction of clinical trials in humans.
References
http://www.newswise.com/articles/nih-researchers-unleash-therapeutic-potential-of-il-35
https://www.nature.com/articles/nm.3554
https://www.nationalmssociety.org/What-is-MS/Definition-of-MS
